Covista Inc. (CVSA) Stock Score, Valuation & Financial Research
Covista Inc. is in the Consumer Defensive sector and Education & Training Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 61/100.
Quick answer for CVSA
Covista Inc. currently has a Wall Street Score of 61/100. The stored market price is $127.2. Its financial score is 33/100. Its valuation score is 93/100. The latest WSS change is +0.1 points. These figures are a research snapshot, not a buy or sell recommendation.
What Covista Inc. does
Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor
CVSA financial snapshot
- Wall Street Score:
- 61/100
- Current price:
- $127.2
- Market capitalization:
- $4.33B
- Revenue:
- $1.95B
- Net income:
- $251.6M
- Free cash flow:
- $392.7M
- Cash:
- $406.3M
- Total debt:
- $905.5M
- EPS:
- 7.55
- P/E ratio:
- 16.8x
- Financial score:
- 33/100
- Valuation score:
- 93/100
- Revenue score:
- 24/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $392.7M, showing positive cash generation.
- The balance sheet shows $406.3M of cash versus $905.5M of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +0.1 points: CVSA increased 0.1 points because overall fundamentals improved.
What the numbers mean
Its current valuation score is 93/100, which Wall Street Score classifies as strong within the model's valuation framework.
The financial score is 33/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-17.
How to research CVSA
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.